1. Home
  2. Laboratory Improvement
  3. Proficiency Testing
  4. New Surveys and Anatomic Pathology Education Programs

New 2026 Surveys and Anatomic Pathology Education Programs

See what's new before you renew your PT/EQA for 2026

We anticipate your PT/EQA needs because laboratory quality drives everything we do. Our PT/EQA programs follow the updated CMS participation requirements so you can continue to deliver accurate and reliable results.

Highlights

  • H5N1 Influenza A Detection and Subtyping program for US laboratories (FLUA)
  • Global program for Dengue Virus Serology (DENS)
  • PT/EQA program for Optical Genome Mapping (OGM)
  • Verification of analytical measurement range with new linearity test covering reticulocytes (LN53)

View all our new programs and decide which ones are right for you.

New PT/EQA Programs for 2025/2026

  • Open all Toggle
  • Close all Toggle
  • Preparation of histologic slides in pathology laboratories with a pediatric caseload (HQPED)
  • PT/EQA program for Human Papillomavirus (High Risk) for Cytopathology (CHPV)
  • Immunohistochemistry Interpretation-only programs for Gastric, Pan Tumor HER2 (GPH/GPH1), HER2 and ER (HERI/HERI1), PD-L1 Tumor Proportion Score IHC (TPS/TPS1)
  • PT/EQA program exclusively for measuring parathyroid hormone levels (PTH)
  •  PT/EQA program for Point-of-Care High-Sensitivity Troponin I (PCHT)
  • Waived Hematocrit, Hemoglobin, and Urinalysis/Urine hCG (HCC3) plus waived Whole Blood Glucose (HCC4)
  • PT/EQA program for Optimal Genome Mapping (OGM)
  • HLA antibody screen only (MXS) or with crossmatching, identification, and extra plasma (MXEP)
  •  PT/EQA program for Thyroid Stimulating Hormone Receptor Binding Antibody (TSHR)
  • Gastrointestinal panel created specifically for laboratories outside the US (GIPN)
  • CLIA-compliant five-challenge PT/EQA programs for rapid malaria (RML5) and Trichomonas vaginalis, molecular (TVG5)
  • PT/EQA program for H5N1 Influenza A Detection and Subtyping for US laboratories (FLUA)*
  • Global PT/EQA program for Dengue Virus Serology (DENS)
  • HIV-1/HIV-2 Detection and Differentiation, Molecular program (HVDD)
  • PT/EQA program Shiga Toxin, extra volume (STX)*

* This program is only available to customers within the US.

  • New PT/EQA offerings for automated (JATXM) and comprehensive methods (JXM) with electronic crossmatch
  • PT/EQA program for Weak RHD Genotyping (WRHG)
  • Red Blood Cell Antigen Typing—Automated program (ARCT)
  • Viral marker for Nucleic Acid Testing, Babesia (NAT1)

New Quality Improvement Programs for 2025/2026

  • Open all Toggle
  • Close all Toggle
  • Calibration verification and linearity covering Factor VIII (LN51), Hepatitis B viral load (LN52), cystatin C (LN49), and a comprehensive panel of thyroid analytes (LN50)
  • Reticulocyte Calibration Verification/Linearity (LN53)

Performance monitors and comparability assessment across multiple instruments for:

  • High-sensitivity cardiac markers (HCRQ)
  • Critical care blood gas with hematocrit and estimated hemoglobin (AQHQ)
  • Critical care blood gas using an i-STAT instrument (AQSQ)

Aid quality improvement efforts and assist checklist requirements in your laboratory with:

  •  Comparative Inpatient Analyte Volumes for Individual and Integrated Laboratories (QPA5/QPA10)

New Continuing Medical Education Programs

Advance skills with educational activities developed by physicians and doctoral scientists with expertise in pathology and laboratory medicine.

  • Discernment of potential discrepancies between biomarker testing modalities for individual (NMBA) and additional participant(s) (NMB1)

New CAP Publications for 2026

Stay current in diagnostic learning with our newest high-quality publications written and edited by recognized experts in pathology and laboratory medicine.

To Top